| iPSC-Derived Hippocampal Neurons | |
|---|---|
| Lineage | iPSC > Neural Progenitor > Hippocampal Neuron |
| Markers | PROX1, CALB1, DCX, MAP2, NEUN |
| Brain Regions | Hippocampus - Dentate Gyrus, CA1, CA3 |
| Disease Relevance | Alzheimer's Disease, Temporal Lobe Epilepsy, Hippocampal Sclerosis |
Ipsc Derived Hippocampal Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-derived hippocampal neurons are in vitro generated neurons that recapitulate the molecular, morphological, and electrophysiological properties of authentic hippocampal neurons. Derived from human induced pluripotent stem cells (iPSCs) through directed differentiation protocols, these neurons express hippocampal-specific markers including PROX1 (dentate gyrus granule cells), CALB1 (CA1 pyramidal neurons), and exhibit functional synaptic connections[1][2].
Standard protocols use dual-SMAD inhibition (SB431542 and LDN-193189) to guide neural ectoderm induction, followed by patterning toward hippocampal fate using WNT activation and BMP inhibition[3].
Hippocampal differentiation proceeds through defined stages:
PROX1-expressing granule cells that form the hippocampal mossy fiber pathway. These neurons are particularly vulnerable in Alzheimer's disease and temporal lobe epilepsy[4].
The primary excitatory neurons of the CA1 subfield, crucial for hippocampal-dependent learning and memory. These neurons show early synaptic dysfunction in Alzheimer's disease models[5].
neurons that receive mossy fiber inputs from dentate gyrus granule cells and participate in pattern separation.
iPSC-derived hippocampal neurons from AD patients exhibit:
Patient-derived neurons model hippocampal sclerosis and reveal neuronal hyperexcitability mechanisms[^6].
Fetal-like maturation state
Variable differentiation efficiency
Lack of glial interactions in monocultures
Absence of blood-brain barrier
Brain Organoid Neurons
iPSC-Derived Striatal Neurons
Dentate Gyrus Hilar Mosaic Neurons
iPSC-derived hippocampal neurons from AD patients provide unique insights:
| Property | Value | Significance |
|---|---|---|
| Resting potential | -60 to -70 mV | Standard neuronal range |
| Input resistance | 1-5 GΩ | Healthy neuronal membrane |
| Membrane capacitance | 20-50 pF | Cell size dependent |
RNA-seq analysis reveals hippocampal neuron signatures:
| Marker | Subtype | Function |
|---|---|---|
| PROX1 | Dentate granule | Transcription factor |
| CALB1 | CA1 pyramidal | Calcium binding |
| WNT2 | Hippocampal pattern | Development |
| nNOS | Interneurons | Nitric oxide |
iPSC-derived hippocampal neurons enable:
| Trial Phase | Application |
|---|---|
| Preclinical | Target engagement |
| Phase I | Safety pharmacology |
| Phase II | Biomarker development |
| Phase III | Patient selection |
The study of Ipsc Derived Hippocampal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Takahashi et al. Induction of pluripotent stem cells from adult human fibroblasts (2007). 2007. ↩︎
Yu et al. Induced pluripotent stem cells from human blood (2009). 2009. ↩︎
Chambers et al. Highly efficient neural conversion of human ESCs (2009). 2009. ↩︎
Palop et al. Network dysfunction in Alzheimer's disease (2012). 2012. ↩︎
Kelley & Benakis, Alzheimer's disease in a dish (2017). 2017. ↩︎